Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Prospective, Observational Trial to Analyze the Relationship Between Single Nucleotide Polymorphism rs2910164 and the Efficacy and Safety of Immune Checkpoint Inhibitor Therapy

NCT04038996 is registered in ClinicalTrials.gov with University of Freiburg as lead sponsor.

NCT NCT04038996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Prospective, Observational Trial to Analyze the Relationship Between Single Nucleotide Polymorphism rs2910164 and the Efficacy and Safety of Immune Checkpoint Inhibitor Therapy
Lead sponsor
University of Freiburg
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
February 29, 2020
Enrollment
179 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer